Novartis has entered into a biotech partnering agreement with a division of Google to in-license its "smart lens" technology for all ocular medical uses. Read the full story
Tag Archive | "opthalmology"
Cooper Companies has acquired Sauflon Pharmaceuticals
Posted on 02 July 2014
The Cooper Companies to acquire Sauflon Pharmaceuticals for $1.2 billion. Read the full story
Pharma alliance between Regeneron and Bayer to develop combination therapy
Posted on 15 January 2014
Regeneron Pharmaceuticals and Bayer Healthcare form a pharma alliance to co-develop a potential combination therapy for $65.5 million. Read the full story
Biotech rumor mill sends pSivida shares up nearly 4%
Posted on 20 June 2013
A blogger's speculation in the biotech rumor mill, that pSivida might be in line for a buyout bid sends the ophthalmology company's shares up nearly 4% today to a 52-week high. Read the full story
Allergan snags rights to retinal disease drug in $420m pact
Posted on 04 May 2011
Determined to use its cache of cash to muscle its way further into the market for retinal diseases, Allergan has paid $45 million upfront and promised up to $375 million more in milestones to nab the global rights to a mid-stage ophthalmology program underway at Switzerland's Molecular Partners AG. Read the full story
